Discovery of 1,5-diaryl-1,2,4-triazole derivatives as myoferlin inhibitors and their antitumor effects in pancreatic cancer.

IF 3.2 4区 医学 Q3 CHEMISTRY, MEDICINAL
Future medicinal chemistry Pub Date : 2022-10-01 Epub Date: 2022-09-27 DOI:10.4155/fmc-2022-0168
Haijun Gu, Ting Zhang, Yunqi Li, Yuan He, Tian Guan, Weiqiong Kan, Peng He, Zhengfang Yi, Yihua Chen
{"title":"Discovery of 1,5-diaryl-1,2,4-triazole derivatives as myoferlin inhibitors and their antitumor effects in pancreatic cancer.","authors":"Haijun Gu, Ting Zhang, Yunqi Li, Yuan He, Tian Guan, Weiqiong Kan, Peng He, Zhengfang Yi, Yihua Chen","doi":"10.4155/fmc-2022-0168","DOIUrl":null,"url":null,"abstract":"<p><p><b>Aim:</b> The first inhibitor targeting myoferlin (MYOF), <b>WJ460</b>, bears poor metabolic stability and water solubility. Therefore, this study aimed to improve the drug-like properties of <b>WJ460</b>. <b>Materials & methods:</b> The authors synthesized an array of 1,5-diaryl-1,2,4-triazole analogs and appraised the binding activities with MYOF and their antiproliferative and antimigratory activities against pancreatic cancer cells. <b>Results:</b> Molecular docking and surface plasmon resonance results showed that <b>E4</b> was directly bound to the MYOF-C2D domain. <b>E4</b> effectively inhibited the proliferation and migration of pancreatic cancer cells <i>in vitro</i>. An <i>in silico</i> study suggested that the water solubility of <b>E4</b> was improved by about 22-times than that of <b>WJ460</b>. <b>Conclusion:</b> The findings suggested that the druglike ability of <b>E4</b> was significantly improved.</p>","PeriodicalId":12475,"journal":{"name":"Future medicinal chemistry","volume":"14 20","pages":"1425-1440"},"PeriodicalIF":3.2000,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future medicinal chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4155/fmc-2022-0168","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/9/27 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: The first inhibitor targeting myoferlin (MYOF), WJ460, bears poor metabolic stability and water solubility. Therefore, this study aimed to improve the drug-like properties of WJ460. Materials & methods: The authors synthesized an array of 1,5-diaryl-1,2,4-triazole analogs and appraised the binding activities with MYOF and their antiproliferative and antimigratory activities against pancreatic cancer cells. Results: Molecular docking and surface plasmon resonance results showed that E4 was directly bound to the MYOF-C2D domain. E4 effectively inhibited the proliferation and migration of pancreatic cancer cells in vitro. An in silico study suggested that the water solubility of E4 was improved by about 22-times than that of WJ460. Conclusion: The findings suggested that the druglike ability of E4 was significantly improved.

1,5-二甲基-1,2,4-三唑衍生物作为肌铁蛋白抑制剂的发现及其在胰腺癌中的抗肿瘤作用。
目的:首个靶向肌铁蛋白(MYOF)的抑制剂 WJ460 的代谢稳定性和水溶性较差。因此,本研究旨在改善 WJ460 的类药物特性。材料与方法:作者合成了一系列 1,5-二芳基-1,2,4-三唑类似物,并评估了它们与 MYOF 的结合活性及其对胰腺癌细胞的抗增殖和抗迁移活性。结果分子对接和表面等离子共振结果表明,E4 与 MYOF-C2D 结构域直接结合。E4 能有效抑制体外胰腺癌细胞的增殖和迁移。硅学研究表明,E4 的水溶性比 WJ460 提高了约 22 倍。结论研究结果表明,E4 的类药物能力显著提高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Future medicinal chemistry
Future medicinal chemistry CHEMISTRY, MEDICINAL-
CiteScore
5.80
自引率
2.40%
发文量
118
审稿时长
4-8 weeks
期刊介绍: Future Medicinal Chemistry offers a forum for the rapid publication of original research and critical reviews of the latest milestones in the field. Strong emphasis is placed on ensuring that the journal stimulates awareness of issues that are anticipated to play an increasingly central role in influencing the future direction of pharmaceutical chemistry. Where relevant, contributions are also actively encouraged on areas as diverse as biotechnology, enzymology, green chemistry, genomics, immunology, materials science, neglected diseases and orphan drugs, pharmacogenomics, proteomics and toxicology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信